CAPG and glioblastoma: Moreover, all key genes that we identified in our study suggested a poor prognosis for GBM patients, therefore, we selected three key genes with significant results (CAPG, CP, and CD44) for Virtual Screening and Molecular Docking, and identified three groups of small molecule compounds as potential therapeutic drugs.